Comparing the Various Breast Cancer Screening Guidelines

Speaker: Myriam Jean Cadet, PhD, FNP-C

Keywords

• Breast cancer screening guidelines
• Mammogram
• Shared decision making

Introduction

• Breast cancer is the second leading cause of death among women.
• Early detection reduces morbidity and mortality.
• Nurse practitioners play a key role in early detection through screening.
• Highlights the importance of understanding various screening guidelines.

Background

• Estimated 42,260 deaths from breast cancer in 2019.
• 268,600 women and 2,670 men living with invasive breast cancer in the US.
• Incidence increases with reproductive history, environmental factors, or genetic mutations.

Risk Factors

Modifiable Risk Factors

• Body Mass Index (BMI): High BMI in postmenopausal women increases risk.
• Diet: Mediterranean diet, especially with extra-virgin olive oil, preventive against breast cancer.
• Physical Activity: Inactivity increases risk, while increased activity reduces it.

Nonmodifiable Risk Factors

• Age: A major risk factor, with 99% of breast cancer occurring in women.
• Family History: Higher risk if there is a family history of breast, ovarian, prostate, pancreatic cancer.
• BRCA1 and BRCA2 gene mutations: Account for up to 30% of inheritable breast cancers.
• Reproductive Factors: Nulliparity, early menarche, late menopause, no breastfeeding, etc.

Breast Disorders and Breast Density

• History of breast disorders like atypical hyperplasia increases risk.
• Dense breast tissue associated with higher risk; dense breast notification laws exist.

Breast Cancer Screening Tools and Guidelines

Risk Assessment Tools

• Breast Cancer Risk Assessment Tool, Gail Model, BRCAPRO, Claus, Tyrer-Cuzick models.
• Limitations in assessing certain populations or genetic mutations.

Screening Modalities

• Debate exists on when to start/stop screening and its benefits/harms.
• Self-breast examination not recommended due to poor validity.
• Clinical breast examination has inconsistent validity and unclear efficacy.

Diagnostic Tests

• Mammography: Mainstay imaging, effective but has false negatives.
• Ultrasonography (USG): Better sensitivity than mammography but lower specificity.
• MRI: Detailed imaging, higher detection but used as supplementary.

Screening Guidelines by Organization

• ACS: Systematic trials, mammogram focus.
• NCCN: Panel review, diverse specialties.
• USPSTF: Systematic reviews, focus on effectiveness.
• ACOG: Risk assessment focus, shared decision-making.
• AAFP: Aligns with USPSTF, emphasizes informed decision-making.

Implications for Practice

• Most guidelines don't recommend screening for those under 40 or over 75.
• Importance of shared decision-making to empower informed patient choices.

Shared Decision-Making Process

• Involves collaboration between provider and patient.
• Helps in understanding patient values and preferences.
• Essential despite being time-consuming.

Education and Literacy

• Important to educate patients beyond guidelines.
• Use clear communication, especially for those with low health literacy.

Research Needs

• Understanding patient readiness, attitudes, and barriers in screening adherence.

Conclusion

• Nurse practitioners need comprehensive understanding of various guidelines.
• They play a critical role in educating and supporting patient decisions on screening.

References

• American Cancer Society, ACOG, USPSTF, etc.
• Supporting literature from various journals and studies.